ATP5MG, also known as ATP synthase mitochondrial F0 complex subunit G or ATP5L, is a key component of the mitochondrial ATP synthase complex (Complex V). This subunit is part of the F0 domain, which forms the transmembrane proton channel critical for oxidative phosphorylation. ATP5MG plays a role in maintaining the structural integrity of the ATP synthase and facilitates proton translocation, thereby driving ATP synthesis. Dysregulation of ATP5MG has been linked to mitochondrial dysfunction, impacting cellular energy metabolism and contributing to diseases such as neurodegenerative disorders, cancer, and metabolic syndromes.
ATP5MG antibodies are essential tools for studying the expression, localization, and function of this subunit in various biological contexts. They are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to assess ATP synthase assembly, mitochondrial membrane protein profiles, or energy metabolism alterations. Researchers employ these antibodies to investigate ATP5MG's role in cellular responses to stress, apoptosis, or metabolic reprogramming in diseases. Commercially available ATP5MG antibodies are typically raised against specific epitopes of human or mouse origin, with validation in model organisms. Proper controls, such as mitochondrial fractionation or knockout validation, are recommended to ensure antibody specificity due to potential cross-reactivity with other mitochondrial proteins.